Aquilo Capital Management as of June 30, 2020
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 14 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Unit Put Option (XBI) | 45.1 | $224M | 2.0M | 111.95 | |
| Dicerna Pharmaceuticals | 7.5 | $37M | 1.5M | 25.40 | |
| Anaptysbio Inc Common (ANAB) | 7.2 | $36M | 1.6M | 22.34 | |
| Uniqure Nv SHS (QURE) | 6.2 | $31M | 680k | 45.06 | |
| Spero Therapeutics (SPRO) | 5.3 | $26M | 1.9M | 13.53 | |
| Blueprint Medicines (BPMC) | 5.0 | $25M | 315k | 78.00 | |
| Arrowhead Pharmaceuticals (ARWR) | 4.9 | $24M | 563k | 43.19 | |
| Ngm Biopharmaceuticals (NGM) | 4.4 | $22M | 1.1M | 19.74 | |
| Regenxbio Inc equity us cm (RGNX) | 4.1 | $20M | 554k | 36.83 | |
| Pieris Pharmaceuticals (PIRS) | 3.5 | $17M | 5.6M | 3.10 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 2.9 | $15M | 2.4M | 6.08 | |
| Galapagos Nv Spon Adr (GLPG) | 1.8 | $8.7M | 44k | 197.29 | |
| Argenx Se Sponsored Adr (ARGX) | 1.6 | $8.1M | 36k | 225.22 | |
| Morphosys Sponsored Ads (MOR) | 0.6 | $3.0M | 96k | 31.67 |
